Efficacy and Safety of Oral L-Ergothioneine Supplementation in Primary Dysmenorrhea: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
In a randomized, double-blind, placebo-controlled trial involving 40 women, oral L-ergothioneine supplementation (120 mg/day) significantly and progressively reduced primary dysmenorrhea pain and associated symptoms over three menstrual cycles without adverse events, suggesting a cytoprotective mechanism independent of classical inflammatory pathways.